|
|
activation of mapk activity involved in innate immune response
|
GO:0035419 |
2 |
0.552
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.528
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.422
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.384
|
|
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
14 |
0.355
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.250
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.225
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.223
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.220
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.201
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.187
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.182
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.181
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.169
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.167
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.167
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.167
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.164
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.164
|
|
|
|
positive regulation of membrane protein ectodomain proteolysis
|
GO:0051044 |
3 |
0.159
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.157
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.156
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.149
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.146
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.143
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.141
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.138
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.137
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.135
|
Human |
|
|
cell adhesion
|
GO:0007155 |
329 |
0.132
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.127
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.127
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.127
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.124
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.121
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.118
|
|
|
|
extracellular matrix dependent thymocyte migration
|
GO:0072680 |
1 |
0.117
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.113
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.112
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.112
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.112
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.111
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.110
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.109
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.108
|
Human |
|
|
prevention of polyspermy
|
GO:0060468 |
4 |
0.107
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.105
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.103
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.102
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.101
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.100
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.099
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.098
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.098
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.098
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.097
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.095
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.095
|
|
|
|
fibronectin dependent thymocyte migration
|
GO:0072681 |
1 |
0.094
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.093
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.092
|
|
|
|
regulation of tumor necrosis factor ligand superfamily member 11 production
|
GO:2000307 |
1 |
0.090
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.090
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.090
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.089
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.089
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.088
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.088
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.087
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.087
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.087
|
Human |
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.087
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.086
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.085
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.084
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.083
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.083
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.083
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.082
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.082
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.081
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.081
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.079
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.078
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.076
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.076
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.074
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.073
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.073
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.073
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.073
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.073
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.072
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.071
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.071
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.070
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.070
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.070
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.070
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.070
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.069
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.069
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.068
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.068
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.068
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.068
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.067
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.066
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.066
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.065
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.065
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.065
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.065
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.064
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.063
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.062
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.062
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.061
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.061
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.060
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.059
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.059
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.059
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.059
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.059
|
|
|
|
cellular extravasation
|
GO:0045123 |
17 |
0.058
|
|
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
21 |
0.057
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.057
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.057
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.056
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.056
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.056
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.056
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.055
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.055
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.055
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.055
|
Human |
|
|
organelle assembly
|
GO:0070925 |
177 |
0.054
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.054
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.054
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.054
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.054
|
|
|
|
positive regulation of tumor necrosis factor ligand superfamily member 11 production
|
GO:2000309 |
1 |
0.053
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.053
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.053
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.052
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.052
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.051
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.051
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.051
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.051
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.051
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.051
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.051
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.051
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.050
|
|
|
|
actin filament depolymerization
|
GO:0030042 |
15 |
0.049
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.049
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.049
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.049
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.049
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.049
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.049
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.049
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.048
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.048
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.048
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.048
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.048
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.048
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.048
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.047
|
|
|
|
regulation of fibronectin dependent thymocyte migration
|
GO:2000413 |
1 |
0.047
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.047
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.047
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.047
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.047
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.046
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.046
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.046
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.046
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.046
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.046
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.045
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.045
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.045
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.045
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.045
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.045
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.045
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.045
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.044
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.044
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.044
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.044
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.044
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.043
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.043
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.043
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.043
|
|
|
|
pma inducible membrane protein ectodomain proteolysis
|
GO:0051088 |
1 |
0.043
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.043
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.042
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.042
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.042
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.042
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.042
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.042
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.042
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.041
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.041
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.041
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.041
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.041
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.041
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.040
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.040
|
|
|
|
regulation of membrane protein ectodomain proteolysis
|
GO:0051043 |
3 |
0.040
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.040
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.040
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.040
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.040
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.040
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.039
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.039
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.039
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.039
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.039
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.039
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.039
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.039
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.039
|
|
|
|
positive regulation of fibronectin dependent thymocyte migration
|
GO:2000415 |
1 |
0.038
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.038
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.038
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.038
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.038
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.037
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.037
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.037
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.037
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.037
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.037
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.037
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.037
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.037
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.037
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.037
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.036
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.036
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.036
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.036
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.035
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.035
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.035
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.035
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.035
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.034
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.034
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.034
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.034
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.034
|
Human |
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.034
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.033
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.033
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.033
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.033
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.033
|
Human |
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.033
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.033
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.033
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.033
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.033
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.033
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.032
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.032
|
Human |
|
|
cognition
|
GO:0050890 |
149 |
0.032
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.032
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.032
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.032
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.032
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.031
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
21 |
0.031
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.031
|
|
|
|
tumor necrosis factor ligand superfamily member 11 production
|
GO:0072535 |
1 |
0.031
|
|
|
|
regulation of microtubule polymerization or depolymerization
|
GO:0031110 |
20 |
0.031
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.031
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.031
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.031
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.031
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.031
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.030
|
Human |
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.030
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.030
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.030
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.030
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.030
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.029
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.029
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.029
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.029
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.029
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.029
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.029
|
|
|
|
learning
|
GO:0007612 |
98 |
0.029
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.029
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.029
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.029
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.028
|
|
|
|
leukocyte aggregation
|
GO:0070486 |
1 |
0.028
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.028
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.028
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.028
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.028
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.028
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.028
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.028
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.028
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.028
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.028
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.027
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.027
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.027
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.027
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.027
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.027
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.027
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.027
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.027
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.027
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.027
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.027
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.027
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.026
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.026
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.026
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.026
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.026
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.026
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.026
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.026
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.026
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.026
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.026
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.026
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.026
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.026
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.026
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.025
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.025
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.025
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.025
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.025
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.025
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.025
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.025
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.025
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.025
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.025
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.025
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.025
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.025
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.024
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.024
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.024
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.024
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.024
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.024
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.024
|
|
|
|
myeloid cell apoptotic process
|
GO:0033028 |
22 |
0.024
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.024
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.024
|
|
|
|
positive regulation of acute inflammatory response
|
GO:0002675 |
16 |
0.024
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.024
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.024
|
|
|
|
chronological cell aging
|
GO:0001300 |
1 |
0.023
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.023
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.023
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.023
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.023
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.023
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.023
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.023
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.023
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.023
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.023
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.023
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.023
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.023
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.023
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.023
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.023
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.022
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.022
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.022
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.022
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.022
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.022
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.022
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.022
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.022
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.022
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.022
|
|
|
|
regulation of cd4 positive alpha beta t cell activation
|
GO:2000514 |
24 |
0.022
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.022
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.022
|
|
|
|
integrin activation
|
GO:0033622 |
8 |
0.022
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.022
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.022
|
|
|
|
germinal center formation
|
GO:0002467 |
16 |
0.022
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.021
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.021
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.021
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.021
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.021
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.021
|
Human |
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.021
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.021
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.021
|
|
|
|
regulation of synaptic vesicle transport
|
GO:1902803 |
13 |
0.021
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.021
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.021
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.021
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.021
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.021
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.021
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.021
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.021
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.021
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.020
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.020
|
|
|
|
positive regulation of lymphocyte apoptotic process
|
GO:0070230 |
13 |
0.020
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.020
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.020
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.020
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.020
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.020
|
|
|
|
negative regulation of insulin receptor signaling pathway
|
GO:0046627 |
14 |
0.020
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.020
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.020
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.020
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.020
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.020
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.020
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.020
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.020
|
|
|
|
negative regulation of t helper 2 cell differentiation
|
GO:0045629 |
4 |
0.020
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.019
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.019
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.019
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.019
|
Human |
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.019
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.019
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.019
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.019
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.019
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.019
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.019
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.019
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.019
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.019
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.019
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.019
|
Human |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.019
|
|
|
|
regulation of homotypic cell cell adhesion
|
GO:0034110 |
13 |
0.019
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.019
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.019
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.018
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.018
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.018
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.018
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.018
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.018
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.018
|
|
|
|
negative regulation of fertilization
|
GO:0060467 |
5 |
0.018
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.018
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.018
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.018
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.018
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.018
|
|
|
|
wound healing involved in inflammatory response
|
GO:0002246 |
4 |
0.018
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.018
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.018
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.018
|
|
|
|
translation
|
GO:0006412 |
93 |
0.018
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.018
|
|
|
|
regulation of protein heterodimerization activity
|
GO:0043497 |
2 |
0.018
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.017
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.017
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
30 |
0.017
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.017
|
|
|
|
membrane raft assembly
|
GO:0001765 |
3 |
0.017
|
|
|
|
hyaluronan metabolic process
|
GO:0030212 |
4 |
0.017
|
|
